Alzheimer's Disease Trial, Recruiting NCT06784830 Sponsor: Sichuan Provincial People's Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06784830
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with dementia according to recognised medical diagnostic guidelines, specifically those used for Alzheimer's disease.

Who may not be able to join:

  • People who have had a stroke, show signs of localised nervous system damage, or whose brain scans show significant small blood vessel disease (confirm with trial site for specific scan score details).
  • People who have other neurological or brain-related conditions, such as depression, brain tumours, Parkinson's disease, metabolic brain disorders, encephalitis, multiple sclerosis, epilepsy, brain injury, or a condition called normal pressure hydrocephalus.
  • People who have other health conditions affecting the body that are known to impact memory and thinking, such as liver or kidney problems, thyroid issues, severe anaemia, certain vitamin deficiencies, syphilis, HIV, or alcohol and drug misuse.
  • People who have an intellectual disability or neurological developmental condition.
  • People who have any other known condition that can cause problems with memory or thinking.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hao Wang, Doctor, Sichuan Provincial People's Hospital

Phone: +8618313820216

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sichuan Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
15 June 2024
Est. completion
30 January 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Comparison of refined nursing and routine nursing intervention in Alzheimer's Patients during PET/CT Imaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov